Shin Nippon Biomedical Laboratories Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shin Nippon Biomedical Laboratories Ltd with three other
companies in this sector in Japan:
Linical Company Limited
sales of 7.67 billion Japanese Yen [US$68.85 million]
of which 93%
was Cro Business),
Sosei Group Corporation
(8.15 billion Japanese Yen [US$73.20 million]
of which 98%
was Overseas Pharmaceutical Business), and
Morishita Jintan Co., Ltd.
(10.43 billion Japanese Yen [US$93.68 million]
of which 63%
was Health Care Business).
During the year ended March of 2016, sales at
Shin Nippon Biomedical Laboratories Ltd were ¥14.75 billion (US$132.46 million).
decrease of 17.3%
versus 2015, when the company's sales were ¥17.84 billion.
Contributing to the drop in overall sales was the 81.4% decline
in Translational Research Project, from ¥50.84 million to ¥9.46 million.
There were also decreases in sales in
Pre-Clinical Business (down 0.4% to ¥11.79 billion)
Clinical Business (down 61.5% to ¥2.13 billion)
Other Businesses (down 65.4% to ¥7.32 million)
However, these declines were partially offset by the increase in sales of
Police Medi (up 105.1% to ¥815.22 million)